[HTML][HTML] 型糖尿病患者血清sTWEAK 水平与动脉粥样硬化斑块的关系
郝伟， 万仁辉， 郑龙轶， 鲁瑾 - 海军军医大学学报, 2022 - html.rhhz.net
目的探讨可溶性肿瘤坏死因子样凋亡弱诱导剂(sTWEAK) 与2 型糖尿病(T2DM)
患者动脉粥样硬化斑块形成的关系. 方法选择2017 年6-12 月于海军军医大学(第二军医大学) …
患者动脉粥样硬化斑块形成的关系. 方法选择2017 年6-12 月于海军军医大学(第二军医大学) …
[PDF][PDF] 维持性血液透析患者血清sTWEAK 水平与冠状动脉钙化的相关性研究
王银娜， 王英， 贾艳丽， 孙懿， 何悦明， 王绿娅 - Age (year), 2015 - biomed.cnjournals.com
摘要目的: 探讨维持性血液透析患者血清可溶性肿瘤坏死因子样凋亡微弱诱导剂(sTWEAK)
水平与冠状动脉钙化的关系. 方法: 选择维持性血液透析患者60 例和健康对照组30 例 …
水平与冠状动脉钙化的关系. 方法: 选择维持性血液透析患者60 例和健康对照组30 例 …
Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease
S Kralisch, M Ziegelmeier, A Bachmann, J Seeger… - Atherosclerosis, 2008 - Elsevier
Recently, circulating soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK)
was introduced as a potential biomarker which is downregulated in atherosclerosis. In the …
was introduced as a potential biomarker which is downregulated in atherosclerosis. In the …
Lower plasma soluble TWEAK concentration in patients with newly diagnosed hypertension
N Karadurmus, S Tapan, M Cakar… - Clinical and …, 2012 - utpjournals.press
Purpose To determine circulating levels of the soluble TNF-like weak inducer of apoptosis
(sTWEAK) and its association with demographic and biochemical parameters in a young …
(sTWEAK) and its association with demographic and biochemical parameters in a young …
Soluble TWEAK levels predict the presence of carotid atherosclerotic plaques in subjects free from clinical cardiovascular diseases
V Fernández-Laso, C Sastre, JM Valdivielso… - Atherosclerosis, 2015 - Elsevier
Objective Reduced soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK)
levels have been related with cardiovascular disease. However, there are no data on the …
levels have been related with cardiovascular disease. However, there are no data on the …
Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease
V Fernández-Laso, N Méndez-Barbero, JM Valdivielso… - Atherosclerosis, 2017 - Elsevier
Background and aims Circulating soluble TNF-like weak inducer of apoptosis (sTWEAK)
concentrations are related to the presence of chronic kidney disease (CKD) and …
concentrations are related to the presence of chronic kidney disease (CKD) and …
Serum sTWEAK concentrations and risk of developing type 2 diabetes in a high cardiovascular risk population: a nested case-control study
Context and Objective: Because serum concentrations of soluble forms of TNF-like weak
inducer of apoptosis (sTWEAK) and scavenger receptor CD163 (sCD163) have been …
inducer of apoptosis (sTWEAK) and scavenger receptor CD163 (sCD163) have been …
Serum sTWEAK levels in chronic periodontitis and type 2 diabetes mellitus
AB Acharya, A Chandrashekar, S Acharya… - Diabetes & Metabolic …, 2019 - Elsevier
Aim The two-way relationship between diabetes mellitus and periodontitis has been
extensively studied with various interconnected biomarkers sharing a link. Soluble Tumour …
extensively studied with various interconnected biomarkers sharing a link. Soluble Tumour …